Metformin Reduces the Incidence of Shoulder Stiffness After Arthroscopic Rotator Cuff Repair: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Este estudio ha sido identificado como potencialmente de alto impacto. La métrica de alto impacto de OE, basada en la inteligencia artificial, estima la influencia que puede tener un artículo integrando señales procedentes tanto de la revista en la que se publica como del contenido científico del propio artículo. Desarrollado mediante el procesamiento del lenguaje natural más avanzado, el modelo de Alto Impacto de OE predice con mayor precisión el futuro rendimiento de las citas de un estudio que el factor de impacto de la revista por sí solo. Esto permite reconocer antes las investigaciones clínicamente significativas y ayuda a los lectores a centrarse en los artículos con más probabilidades de configurar la práctica futura.

Resumen del estudio

This randomized, double-blinded, placebo-controlled trial enrolled 146 patients undergoing arthroscopic rotator cuff repair for full-thickness, nontraumatic small to large-sized rotator cuff tears. Patients were randomized 1:1 to receive either a placebo or 500 mg of metformin twice daily, for three months postoperatively. After loss to follow-up, 126 patients completed the study and were included in the final analysis (64 metformin, 62 control). The primary outcome was the incidence of postoperative shoulder stiffness at 3 months; secondary outcomes included American Shoulder and Elbow Surgeons (ASES) score, pain (VAS), patient satisfaction, plasma fibrotic biomarkers, and rotator cuff tendon healing assessed by ultrasonography. Outcomes were assessed at 3 months, 6 months, and 1 year postoperatively. Overall, the results of the study revealed a significantly lower incidence of shoulder stiffness in the metformin group compared with placebo at all postoperative time points, without adverse effects on tendon healing or clinically meaningful differences in long-term functional outcomes.